Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001123292-19-000437

Options or other derivatives

  • Chief Scientific Officer acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sofia Michael J. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-01 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +145,000 145,000 D
Loading xslF345X03/edgar.xml…